Breast cancer

Breast cancer is the commonest cancer in women in the UK. There are over 40,000 new cases every year. It is important to realize that half of all new cases are middle aged or older, ie over 65 years

Read more....

Ovarian Cancer

Ovarian cancer can affect women of any age, although it is most common in those between 55 and 65 years of age Even though ovarian cancer is a rare disease, it is the number one cause of death among

Read more....

Oesophageal Cancer

The oesophagus is part of the digestive system. The oesophagus is the long tube that carries food from the throat to the stomach. The top part of the oesophagus lies behind the windpipe (trachea).

Read more....

Uterine Cancer

The uterus, commonly known as the womb, is the part of the female reproductive system where the baby is carried during pregnancy. The uterus is lined by a layer of cells called the endometrium. The

Read more....

Cervical Cancer

The cervix is a distinct part of the womb, being the narrow 'neck' of the womb that links it to the vagina. Cervical cancer often has no symptoms in its early stages. If you have symptoms, the most

Read more....

Colon Cancer

Colon cancer is the third commonest cancer in the UK and accounts for over 40,000 new cases every year. The diagnosis is usually based on a change of bowel habit which can comprise symptoms of

Read more....

Diagnostics Service

The diagnostics service we provide at Queen Anne Street Medical Centre comprises all the modern radiological and pathological diagnostic capabilities necessary to manage cancer. Virtually all tests

Read more....

Molecular MDT Service

We run regular meetings with expert colleagues to discuss the management of all new cases. The focus of this Multidisciplinary meeting is to review the pathology of the cancer with emphasis on the

Read more....

Our Philosophy

We believe that patients deserve to be offered the best advice that science can provide on the diagnosis and treatment of their cancer.

If we do not have access to the relevant technology (eg a new anti-cancer drug), we will find out where it may be obtained. This would possibly involve the patient looking at a clinical trial.

However we also believe that advice and care should be given in a sympathetic way that recognises the patient’s perspective. Any management or treatment plan is always the result of a dialogue between the specialist and the patient where the patient’s views are integral in the process of arriving at a decision.

We have always practised medicine in such a way that gives the greatest respect to the patient’s needs and concerns.

This recognition of what is needed, of course, extends to include the patient’s family and carers if that is what the patient desires.

Intraperitoneal Therapy

Anti-Cancer antibodies directly targeting ovarian cancer in the abdomen.

Profiling Cancers

To identify potential drug targets to optimise effectiveness of chemotherapy.

Prof. R. Leonard
Breast, Bowel Cancer and Lymphoma Specialist

Prof. R. Leonard

Breast, Bowel Cancer and Lymphoma Specialist

- 30 years clinical experience
- Reaserch interest in breast cancer
- Led many clinical trials
- Clinical director Maggie's Cancer Caring
- Current research cancer in older women

Is a medical oncologist with a major interest in the management of breast cancer. He is Professor of Cancer Studies at Imperial College London and honorary consultant medical oncologist at Imperial College NHS Trust; The BUPA Cromwell Hospital, The London Clinic and the London Oncology Clinic.
Academic roles have included 25 years in senior Academic and NHS administrative roles in London, Edinburgh and Swansea.

Prof. H. Gabra
Gynaecological and GI Cancer Specialist

Prof. H. Gabra

Gynaecological and GI Cancer Specialist

- 20 years clinical experience
- Laboratory research learder in ovarian cancer
- Clinical trialist
- Advisor to Cancer Research UK and Ovarian Cancer Action

Is a medical oncologist with a major interest in the management of gynaecological cancer. He is Professor of Cancer Medicine at Imperial College London and honorary consultant medical oncologist at Imperial College NHS Trust; The BUPA Cromwell Hospital, The London Clinic and the London Oncology Clinic (Leaders in Oncology Care). He is a key opinion leader with an internationally leading reputation in the research into and treatment of ovarian cancer.